Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. - Wikidata - awgldk - TriplyDB

Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.

Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.

http://www.wikidata.org/entity/Q50579651

about

Immunoglobulin GM and KM Allotypes and Prevalence of Anti-LKM1 Autoantibodies in Patients with Hepatitis C Virus Infection Autoantibodies in chronic hepatitis C: A clinical perspective Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.Clinical significance of the detection of antinuclear antibodies in patients with acute hepatitis a.The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.Autoantibodies in hepatitis C: red flag or bystander effect?Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection.Study of non-organ-specific antibodies in children with genotype 4 chronic hepatitis C.Autoimmunity and extrahepatic manifestations in treatment-naïve children with chronic hepatitis C virus infection.Host factors determining the efficacy of hepatitis C treatment.Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.Diagnostic approach to autoimmune hepatitis.Evaluating the performance of the focus HerpeSelect® HSV-2 IgG in veterans with chronic hepatitis C infection.A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin.Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.Autoantibody profile in individuals with chronic hepatitis C.Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.

P2860

Q27473220-0A532199-E7E4-406B-8E47-8FB58ABD2AE4 Q28088556-1E6E3FA8-C4AD-4A9C-BFF0-F9E16F55B18A Q34626547-FC07FCA4-DE5B-4425-9338-BA81EA6A8C9D Q35195460-5B172B15-E80E-47DD-A899-B09B84C18AF3 Q35914823-699829D3-42F3-4CF9-9AA2-968375D9BDDF Q36231193-CA0DB32F-F366-4426-9766-3DA7721A2BDD Q36644830-A0015E35-7CA0-414C-A535-D43869D6C9A4 Q37413335-A53C0D43-AD88-43FD-9233-68048BA4F9CC Q37645723-48AEDB29-26B6-4DCB-80FE-B6DF56C7E284 Q38014438-CC6FA954-1268-4F89-A815-961AA1C881A4 Q38056077-7204818D-3DB9-4C51-9F3E-4D305644A36F Q38497449-8782B79D-24AC-4C27-A83B-ABC1DA075E4E Q39130785-368C5CD0-8EC7-4599-8354-E6EB57A72787 Q39290190-077FF782-D78F-4256-A851-2B07C321F374 Q41290459-126976C9-28BB-423E-900B-1467E98ABD0E Q44739483-35AFB09E-83EB-4FCB-B8D8-92E960CD37CB Q45985033-003B6EF2-6F73-410B-8D31-0B5527A861BC Q46789982-739F8427-3565-4497-9DE9-1EE085BB88B5 Q50550677-9429D340-321A-45B4-AE96-4BA029455C27 Q50574844-FBFE085C-92F4-441D-92FF-FF72823E1BB8 Q50933723-63AB5219-ACF4-4AF9-879C-1DBAD3A2909B Q55027429-B7A0A145-5CAD-47DD-950B-FEA0502AECF1

P2860

Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.

http://www.wikidata.org/entity/Q50579651

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Clinical impact of non-organ-s ...... in patients with hepatitis C.

@en

Clinical impact of non-organ-s ...... in patients with hepatitis C.

@nl

type

label

Clinical impact of non-organ-s ...... in patients with hepatitis C.

@en

Clinical impact of non-organ-s ...... in patients with hepatitis C.

@nl

prefLabel

Clinical impact of non-organ-s ...... in patients with hepatitis C.

@en

Clinical impact of non-organ-s ...... in patients with hepatitis C.

@nl

P1433

Q50579651-B2E82F9D-64AA-4359-9A0B-411BCA13F668

P1476

Q50579651-833D5D01-AE91-40AF-A77D-8C957CDADB74

P2093

Q50579651-3A14925A-DCDC-4A3A-B077-7E6EB437336C

Q50579651-5CD12654-C57C-48F4-A402-A091B0B53FFF

Q50579651-5F4026B0-066E-4CE8-B1EE-E53B720147F6

Q50579651-93A0212D-83F3-496B-A9DA-646C7768836D

Q50579651-AA94028B-2208-43F3-BB2E-592F13A14D4F

Q50579651-B274CE31-496E-4BF6-8B89-30A3728D991B

P304

Q50579651-3D7BF75E-FEAE-4EDF-A7D8-595A3F0B4327

P31

Q50579651-9F3A05C6-514A-43B1-AC12-32BC213DA88C

P356

Q50579651-1E783449-22B1-4983-B712-BF9A97210015

P407

Q50579651-A3BA0889-9011-4F6F-A482-1490F9CE2964

P433

Q50579651-CE6A19C5-8409-46DA-92C6-595289C921D5

P478

Q50579651-EB507FC8-2DF4-4BC9-8CCA-9A4473B767CF

P50

Q50579651-A550A375-4D37-474F-A6AB-7FD4CF2CA99D

P577

Q50579651-9EFA9B38-E18D-4766-944E-310C3BDAE385

P5875

Q50579651-5FA52A00-2C56-464A-8E05-41005F8ED6E8

P698

Q50579651-DC90CE5D-CD4E-4430-A06E-F05698E3334F

P921

Q50579651-70366F02-8D90-4E0D-87A0-A37A126412C5

Q50579651-A938F20D-C5D4-46EE-8506-C8EC17FE443B

P356

P1433

Clinical Infectious Diseases

P1476

Clinical impact of non-organ-s ...... in patients with hepatitis C.

@en

P2093

Francesco B Bianchi

http://www.w3.org/2001/XMLSchema#string

Luigi Muratori

http://www.w3.org/2001/XMLSchema#string

Marcello Guidi

http://www.w3.org/2001/XMLSchema#string

Marco Lenzi

http://www.w3.org/2001/XMLSchema#string

Micaela Susca

http://www.w3.org/2001/XMLSchema#string

Paolo Muratori

http://www.w3.org/2001/XMLSchema#string

P304

501-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/427285

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Granito

P577

2005-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8021290

http://www.w3.org/2001/XMLSchema#string

P698

15712070

http://www.w3.org/2001/XMLSchema#string

P921